comparemela.com
Home
Live Updates
Medtronic touts 3-year data for Evolut TAVR : comparemela.com
Medtronic touts 3-year data for Evolut TAVR
Medtronic (NYSE:MDT) announced three-year data supporting its Evolut transcatheter aortic valve replacement (TAVR) system.
Related Keywords
John Forrest ,
Corevalve Evolut ,
Medtronic Evolut ,
Nina Goodheart ,
World Heart Federation Congress ,
Yale School Of Medicine ,
Journal Of The American College Cardiology ,
American College Of Cardiology ,
Medtronic ,
Evolut Low Risk ,
American College ,
Annual Scientific Session Together ,
World Heart Federation ,
World Congress ,
Yale School ,
Evolut Low Risk Trial ,
Structural Heart ,
comparemela.com © 2020. All Rights Reserved.